COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Budget du Québec - Les ressources intermédiaires : Partenaires oubliés du gouvernement28/03/2018
-   
  OncBioMune Returns Protocol to Scientific Review Committee Overseeing Phase 2 Prostate Cancer Clinical Trial28/03/2018
-   
  Arcturus Therapeutics Issues Open Letter to Shareholders28/03/2018
-   
  ATW Tech Announces a Contemplated Private Placement of $1.5 Million28/03/2018
-   
  ATW Tech annonce une proposition de placement privé de 1,5 million28/03/2018
-   
  Pacgen Announces New Management Structure and Reports on P113 Commercial Progress28/03/2018
-   
  Western Maryland Health System Chooses Artifact Health’s Mobile Platform to Simplify and Automate the Physician Query Process28/03/2018
-   
  Orion Biotechnology Canada Announces Partnership with Nanjing University28/03/2018
-   
  TOMI Environmental Solutions, Inc. to Hold Fourth Quarter 2017 Financial Results Conference Call on Monday, April 2, 201828/03/2018
-   
  Editas Medicine Names James C. Mullen as Chairman of the Board of Directors28/03/2018
-   
  Progyny to Sponsor 2018’s National Infertility Awareness Week® and Night of Hope Which Supports RESOLVE: The National Infertility Association28/03/2018
-   
  Shire plc : Statement re Possible Offer28/03/2018
-   
  American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention28/03/2018
-   
  Interpace Diagnostics Announces Agreement with Acupath Laboratories28/03/2018
-   
  Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.28/03/2018
-   
  Histogenics Corporation to Present at Upcoming Investor Conferences28/03/2018
-   
  Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics28/03/2018
-   
  Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference28/03/2018
-   
  Apricus Biosciences Announces Pricing of $3.55 Million Public Offering28/03/2018
Pages